» Articles » PMID: 32140489

Modification of the 8 AJCC Staging System of Pancreatic Ductal Adenocarcinoma

Overview
Date 2020 Mar 7
PMID 32140489
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

Long non-coding RNA MIR4435-2HG promotes pancreatic cancer progression by regulating ABHD17C through sponging miR-128-3p.

Chen Z, Du Y, Shi H, Dong S, He R, Zhou W Transl Cancer Res. 2024; 13(8):4113-4130.

PMID: 39262472 PMC: 11385540. DOI: 10.21037/tcr-24-51.


MR Molecular Image Guided Treatment of Pancreatic Cancer with Targeted ECO/miR-200c Nanoparticles in Immunocompetent Mouse Tumor Models.

Laney V, Hall R, Yuan X, Hampson E, Halle A, Yeung G Pharm Res. 2024; 41(9):1811-1825.

PMID: 39198318 PMC: 11436418. DOI: 10.1007/s11095-024-03762-7.


Levels of retinol and retinoic acid in pancreatic cancer, type-2 diabetes and chronic pancreatitis.

Hrabak P, Zelenkova M, Krechler T, Soupal J, Vocka M, Hanus T Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023; 168(2):132-138.

PMID: 38058194 DOI: 10.5507/bp.2023.049.


Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy.

Tong Y, Lai Z, Katz M, Prakash L, Wang H, Chatterjee D Cancers (Basel). 2023; 15(9).

PMID: 37174073 PMC: 10177033. DOI: 10.3390/cancers15092608.


New nomogram for predicting lymph node positivity in pancreatic head cancer.

Guo X, Song X, Long X, Liu Y, Xie Y, Xie C Front Oncol. 2023; 13:1053375.

PMID: 36761960 PMC: 9907461. DOI: 10.3389/fonc.2023.1053375.


References
1.
Chatterjee D, Katz M, Foo W, Sundar M, Wang H, Varadhachary G . Prognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Therapy. Am J Surg Pathol. 2017; 41(8):1097-1104. PMC: 5527751. DOI: 10.1097/PAS.0000000000000887. View

2.
Vuarnesson H, Lupinacci R, Semoun O, Svrcek M, Julie C, Balladur P . Number of examined lymph nodes and nodal status assessment in pancreaticoduodenectomy for pancreatic adenocarcinoma. Eur J Surg Oncol. 2013; 39(10):1116-21. DOI: 10.1016/j.ejso.2013.07.089. View

3.
Saka B, Balci S, Basturk O, Bagci P, Postlewait L, Maithel S . Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Rendering the AJCC T-Stage Protocol (7th Edition) Inapplicable and Insignificant: A Size-Based Staging System (pT1: ≤2, pT2: >2-≤4, pT3:.... Ann Surg Oncol. 2016; 23(6):2010-8. PMC: 5389382. DOI: 10.1245/s10434-016-5093-7. View

4.
Allen P, Kuk D, Fernandez-Del Castillo C, Basturk O, Wolfgang C, Cameron J . Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma. Ann Surg. 2016; 265(1):185-191. PMC: 5611666. DOI: 10.1097/SLA.0000000000001763. View

5.
Huebner M, Kendrick M, Reid-Lombardo K, Que F, Therneau T, Qin R . Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma. J Gastrointest Surg. 2012; 16(5):920-6. DOI: 10.1007/s11605-012-1853-2. View